UNVC Stock Overview

Through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. More details

UNVC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($8M)

Latest financial reports are more than a year old

Highly volatile share price over the past 3 months compared to the US market

My Notes

Capture your thoughts, links and company narrative

Univec, Inc. Competitors

Meihua International Medical Technologies

NasdaqGM:MHUA

US$11.0m

Innovative Eyewear

NasdaqCM:LUCY

US$12.4m

InVitro International

OTCPK:IVRO

US$2.0m

Procyon

OTCPK:PCYN

US$1.5m

Price History & Performance

Summary of share price highs, lows and changes for Univec
Historical stock prices
Current Share Price	US$0.0026
52 Week High	US$0.013
52 Week Low	US$0.0014
Beta	0
1 Month Change	21.43%
3 Month Change	-12.07%
1 Year Change	-63.83%
3 Year Change	-93.49%
5 Year Change	-73.98%
Change since IPO	-99.97%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	UNVC	US Medical Equipment	US Market
7D	15.9%	-0.2%	0.2%
1Y	-63.8%	14.4%	23.1%

Return vs Industry: UNVC underperformed the US Medical Equipment industry which returned 13.3% over the past year.

Return vs Market: UNVC underperformed the US Market which returned 21% over the past year.

Price Volatility

Is UNVC's price volatile compared to industry and market?
UNVC volatility
UNVC Average Weekly Movement	29.8%
Medical Equipment Industry Average Movement	8.1%
Market Average Movement	5.9%
10% most volatile stocks in US Market	18.3%
10% least volatile stocks in US Market	3.0%

Stable Share Price: UNVC's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: UNVC's weekly volatility has increased from 25% to 30% over the past year.

About the Company

Founded	Employees	CEO	Website
1992	n/a	David Dalton	www.univec.com

Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines.

Univec, Inc. Fundamentals Summary

How do Univec's earnings and revenue compare to its market cap?
UNVC fundamental statistics
Market cap	US$7.57m
Earnings (TTM)	-US$650.34k
Revenue (TTM)	US$28.63k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is UNVC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
UNVC income statement (TTM)
Revenue	US$28.63k
Cost of Revenue	US$42.94k
Gross Profit	-US$14.31k
Other Expenses	US$636.03k
Earnings	-US$650.34k

Last Reported Earnings

Sep 30, 2007

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did UNVC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/11 10:10
End of Day Share Price	2025/02/11 00:00
Earnings	2007/09/30
Annual Earnings	2006/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Univec, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.